tiprankstipranks
Innovation1 Biotech (IVBT)
OTHER OTC:IVBT
US Market

Innovation1 Biotech (IVBT) Financial Statements

11 Followers

Innovation1 Biotech Financial Overview

Innovation1 Biotech's market cap is currently $4.49K. The company's EPS TTM is $-0.3033; its P/E ratio is ―; Innovation1 Biotech is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Aug 23Aug 22Aug 21Aug 20Aug 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 3.08K$ 1.18K$ 79.25K
Gross Profit$ -52.70K$ -2.55M$ 1.66K$ -1.78K$ -50.09K
Operating Income$ -1.37M$ -5.25M$ -258.44K$ -217.00K$ -627.00K
EBITDA$ -5.68M$ -38.33M$ 1.26M$ -1.28M$ -168.00K
Net Income$ -5.99M$ -40.88M$ 1.04M$ -2.58M$ -170.00K
Balance Sheet
Cash & Short-Term Investments$ 49.85K$ 156.49K$ 137.48K$ 17.88K$ 18.98K
Total Assets$ 75.99K$ 43.96M$ 181.89K$ 208.60K$ 256.41K
Total Debt$ 229.00K$ 507.63K$ 160.00K$ 841.17K$ 76.55K
Net Debt$ 179.15K$ 351.14K$ 22.52K$ 823.29K$ 57.57K
Total Liabilities$ 3.51M$ 41.11M$ 406.73K$ 2.89M$ 224.05K
Stockholders' Equity$ -3.43M$ 2.85M$ -224.84K$ -2.68M$ 32.36K
Cash Flow
Free Cash Flow$ -620.20K$ -3.13M$ -30.41K$ -410.25K$ -782.49K
Operating Cash Flow$ -620.20K$ -3.13M$ -30.41K$ -410.25K$ -775.93K
Investing Cash Flow$ 0.00$ -853.14K$ 0.00$ -300.00K$ -6.56K
Financing Cash Flow$ 513.56K$ 4.00M$ 150.00K$ 709.15K$ 27.00K
Currency in USD

Innovation1 Biotech Earnings and Revenue History

Innovation1 Biotech Debt to Assets

Innovation1 Biotech Cash Flow

Innovation1 Biotech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.